patients

The American College of Cardiology has published a case study examining what happens when patient care breaks down within the business side of medicine. The piece walks through a real-world failure in care delivery and draws lessons for cardiologists and practice managers on preventing similar breakdowns in coordination, communication, or operations.

Attention is turning to the psychological toll of multiple myeloma and smouldering myeloma, with cancer care specialists stressing that emotional support should be part of treatment. Patients with smouldering myeloma, who are often monitored without immediate treatment, can face significant anxiety and uncertainty, and clinicians are calling for mental health needs to be addressed alongside medical care.

A new report funded by PhRMA estimates that hospitals, clinics and their for-profit partners received $142 billion in 2025 through the federal 340B drug discount program. The figure is likely to fuel debate over whether the program, meant to help safety-net providers serve low-income patients, has grown beyond its original intent, with pharmaceutical manufacturers arguing discounts are being pocketed rather than passed on to patients.

Novo Nordisk is lowering the price of its weight-loss drug Wegovy by 20 percent in Sweden, according to multiple Swedish business and news outlets. The move comes as GLP-1 medicines, once marketed primarily as obesity treatments for patients, are increasingly described in industry coverage as lifestyle drugs competing for customers, intensifying pressure on pricing.

Ten NHS staff members are under investigation in connection with access to the medical records of Noah Woods, according to Sky News. The inquiry relates to potential breaches of patient confidentiality. The boy's case has drawn widespread public attention, and the investigation raises questions about how healthcare staff handle sensitive patient data.

Therapists report a growing number of clients bringing fears about artificial intelligence into their sessions, according to a New York Times report. Patients describe worry over job loss, misinformation and a loss of human control, adding a new dimension to conventional anxiety treatment. Mental health professionals are now adapting their approaches to address these technology-driven concerns.

Health guidance on fatty liver disease is drawing wide attention, with discussion focused on how grades 1, 2 and 3 of the condition can be reversed through treatment, diet changes and exercise. Interest spans Punjabi-speaking audiences, where the condition is known as ਜਿਗਰ ਦੀ ਚਰਬੀ, and reflects growing concern about lifestyle-related liver problems and what practical steps patients can take.

A new commentary argues that the mental health of healthcare workers must become a leadership priority, not just an individual concern. Writing in South Florida Hospital News, the piece calls on hospital executives to address burnout and emotional strain among caregivers, framing staff wellbeing as essential to patient care quality and workforce retention across the sector.

Researchers report that some people with Long Covid carry autoantibodies targeting neuronal cells, but no single antibody signature defines the illness. Commenters say the findings fit a heterogeneous disease picture, comparing Long Covid and ME/CFS to conditions with autoimmune components rather than classic autoimmune diseases like multiple sclerosis. Many say the lack of a uniform marker mirrors their own clinical experience and explains why diagnosis and treatment remain so difficult.

CPAP Medical Supplies and Services has agreed to pay up to $500,000 to settle a class action lawsuit stemming from a data breach, according to reporting by The HIPAA Journal. The settlement resolves claims that the company failed to adequately protect patient information exposed in the incident.

Northeast Rehabilitation Hospital Network, a provider of rehabilitation services in New England, is the subject of reports concerning a possible data breach affecting patient information. Details about the scope, number of individuals impacted, and types of data exposed have not been fully confirmed. Cybersecurity watchers are monitoring the situation for official statements from the hospital network and potential regulatory or legal follow-up.

Attention is turning to gedatolisib, an investigational PI3K/mTOR inhibitor being studied for hormone receptor-positive, HER2-negative metastatic breast cancer. Coverage from CancerNetwork highlights the drug's toxicity profile and the need for better patient and clinician education around managing side effects during treatment. The discussion centres on how safety monitoring and awareness may shape its use if the therapy advances toward approval.

Five-year clinical trial data for brogidirsen (NS-089/NCNP-02), an investigational treatment for Duchenne muscular dystrophy, has been presented at the 2026 World Muscle Society Congress. The long-term results are being shared with specialists in neuromuscular medicine, offering the fullest picture yet of the drug's safety and effectiveness over five years in patients with the muscle-wasting disease.

A new report covering healthcare data breaches in the first half of 2026 has been published, compiling incidents involving patient and medical data. The report catalogs breach counts, affected records, and causes such as hacking and unauthorized disclosure across the healthcare sector. The healthcare industry remains one of the most targeted sectors for cyberattacks, making such periodic reports a reference point for compliance officers, regulators, and security teams monitoring patient data protection.

New radiotherapy trials are underway that could redefine how brain metastases are treated, according to Physics World. The trials are testing refinements in radiation delivery and dosing for patients whose cancer has spread to the brain, aiming to improve tumour control while reducing damage to healthy tissue and side effects. Researchers say the results could influence clinical guidelines and standard practice for a growing group of patients as cancer survival overall improves.

Attorneys are looking into reports of a data breach involving the Northern NJ Eye Institute, potentially affecting patients' personal information. The investigation, publicised via a consumer advocacy page, is in early stages, and it is not yet confirmed whether a breach occurred or how many people may be impacted. Affected individuals are being asked to come forward with details.